These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 29040754)
1. Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6. Hua CK; Gacerez AT; Sentman CL; Ackerman ME Protein Eng Des Sel; 2017 Oct; 30(10):713-721. PubMed ID: 29040754 [TBL] [Abstract][Full Text] [Related]
2. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30. Butler SE; Brog RA; Chang CH; Sentman CL; Huang YH; Ackerman ME Cancer Immunol Immunother; 2022 Jan; 71(1):165-176. PubMed ID: 34046711 [TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression. Gacerez AT; Hua CK; Ackerman ME; Sentman CL Cancer Immunol Immunother; 2018 May; 67(5):749-759. PubMed ID: 29453518 [TBL] [Abstract][Full Text] [Related]
4. B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells. Phillips M; Romeo F; Bitsaktsis C; Sabatino D Biopolymers; 2016 Sep; 106(5):658-72. PubMed ID: 27216712 [TBL] [Abstract][Full Text] [Related]
5. B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines. Bjørnsen EG; Thiruchelvam-Kyle L; Hoelsbrekken SE; Henden C; Saether PC; Boysen P; Daws MR; Dissen E Eur J Immunol; 2019 Jan; 49(1):54-65. PubMed ID: 30512185 [TBL] [Abstract][Full Text] [Related]
6. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody. Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798 [TBL] [Abstract][Full Text] [Related]
7. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance. Kilian M; Friedrich MJ; Lu KH; Vonhören D; Jansky S; Michel J; Keib A; Stange S; Hackert N; Kehl N; Hahn M; Habel A; Jung S; Jähne K; Sahm F; Betge J; Cerwenka A; Westermann F; Dreger P; Raab MS; Meindl-Beinker NM; Ebert M; Bunse L; Müller-Tidow C; Schmitt M; Platten M Sci Immunol; 2024 May; 9(95):eadj7970. PubMed ID: 38701193 [TBL] [Abstract][Full Text] [Related]
9. Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy. Gutierrez-Franco J; Hernandez-Gutierrez R; Bueno-Topete MR; Haramati J; Navarro-Hernandez RE; Escarra-Senmarti M; Vega-Magaña N; Del Toro-Arreola A; Pereira-Suarez AL; Del Toro-Arreola S Immunobiology; 2018 Jan; 223(1):57-63. PubMed ID: 29055565 [TBL] [Abstract][Full Text] [Related]
10. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity. Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331 [TBL] [Abstract][Full Text] [Related]
11. Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC. Flajnik MF; Tlapakova T; Criscitiello MF; Krylov V; Ohta Y Immunogenetics; 2012 Aug; 64(8):571-90. PubMed ID: 22488247 [TBL] [Abstract][Full Text] [Related]
12. The integrated stress response promotes B7H6 expression. Obiedat A; Charpak-Amikam Y; Tai-Schmiedel J; Seidel E; Mahameed M; Avril T; Stern-Ginossar N; Springuel L; Bolsée J; Gilham DE; Dipta P; Shmuel M; Chevet E; Mandelboim O; Tirosh B J Mol Med (Berl); 2020 Jan; 98(1):135-148. PubMed ID: 31838577 [TBL] [Abstract][Full Text] [Related]